Human SOD2 modification by dopamine quinones affects enzymatic activity by promoting its aggregation: possible implications for Parkinson's disease

Human SOD2 modification by dopamine quinones affects enzymatic activity by promoting its aggregation: possible implications for Parkinson's disease

Item
http://www.wikidata.org/entity/Q34313803
Oxidative stress and Parkinson's diseaseNovel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's diseaseClassification of oxidative stress based on its intensityBehavioral and neurotransmitter abnormalities in mice deficient for Parkin, DJ-1 and superoxide dismutase.Dopamine quinone modifies and decreases the abundance of the mitochondrial selenoprotein glutathione peroxidase 4.Network analysis identifies SOD2 mRNA as a potential biomarker for Parkinson's disease.Oxidative and nitrative stress in neurodegeneration.Leukemia Inhibitory Factor Protects Neurons from Ischemic Damage via Upregulation of Superoxide Dismutase 3.Mitochondrial metals as a potential therapeutic target in neurodegeneration.Induction of NQO1 and Neuroprotection by a Novel Compound KMS04014 in Parkinson's Disease Models.Targeting antioxidant enzyme expression as a therapeutic strategy for ischemic stroke.Does Vitamin C Influence Neurodegenerative Diseases and Psychiatric Disorders?Association Analysis Suggests SOD2 as a Newly Identified Candidate Gene Associated With Leprosy Susceptibility.PCB95 and PCB153 change dopamine levels and turn-over in PC12 cells.Stabilization of Alpha-Synuclein Oligomers In Vitro by the Neurotransmitters, Dopamine and Norepinephrine: The Effect of Oxidized Catecholamines.Superoxide dismutating molecules rescue the toxic effects of PINK1 and parkin loss.
P2860

Human SOD2 modification by dopamine quinones affects enzymatic activity by promoting its aggregation: possible implications for Parkinson's disease

Item
http://www.wikidata.org/entity/Q34313803
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Human SOD2 modification by dop ...... ations for Parkinson's disease
@ast
Human SOD2 modification by dop ...... ations for Parkinson's disease
@en
Human SOD2 modification by dop ...... ations for Parkinson's disease
@nl
type
label
Human SOD2 modification by dop ...... ations for Parkinson's disease
@ast
Human SOD2 modification by dop ...... ations for Parkinson's disease
@en
Human SOD2 modification by dop ...... ations for Parkinson's disease
@nl
prefLabel
Human SOD2 modification by dop ...... ations for Parkinson's disease
@ast
Human SOD2 modification by dop ...... ations for Parkinson's disease
@en
Human SOD2 modification by dop ...... ations for Parkinson's disease
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Human SOD2 modification by dop ...... ations for Parkinson's disease
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0038026
P407
P433
P478
P50
P577
P5875
P698
P921
P932